Andere talen Virios Therapeutics, Inc.

Aandelen

VIRI

US92829J1043

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,4252 ^USD	-1,35%		-5,70%	-26,05%

29/02	Virios Therapeutics, Inc. rapporteert winstresultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI
22/01	Virios Therapeutics kondigt plannen aan om de ontwikkeling van Imc-2 te bevorderen als behandeling voor symptomen die gepaard gaan met Long-Covid	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID	26/03
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	01/03
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	29/02
Virios Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02
Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results	29/02
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones	28/02
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID	22/01
Virios Therapeutics Announces Plans to Advance Development of Imc-2 as Treatment for Symptoms Associated with Long-Covid	22/01
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID	02/01
Virios Therapeutics, Inc. Reaches Alignment with FDA on Requirements for Advancing Development Candidate IMC-2 as Treatment for Long-COVID	02/01
Virios Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Virios Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update	13/11
Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023	06/11
Thinking about buying stock in Aware, Virios Therapeutics, Bit Brother, Confluent, or Blue Star Foods?	03/11
Virios Therapeutics to Present at the ThinkEquity Conference on Thursday, October 19, 2023	12-10-23
Virios Therapeutics, Inc. Announces Termination of At-The-Market Sales Agreement	18-09-23
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement	18-09-23
Virios Therapeutics CEO Greg Duncan to Present at the SHARE Series Investor Event on Monday, September 18, 2023	13-09-23
Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023	12-09-23
Virios Therapeutics Announces Halt to At-The-Market Offering Sales	14-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Virios Therapeutics, Inc.

Aandelen

VIRI

US92829J1043

Andere talen

Filters